Akums Drugs and Pharmaceuticals Limited (AKUMS.NS) share price
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS.NS) last traded at INR 743.8, down 0.11% on the day (quote 2026-11-08 10:00 UTC), with a market cap of INR 11387.7 Cr and a 52-week range of INR 409.3 to INR 838.8.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 743.8 |
| 1-day move | -0.11% |
| 52-week range | INR 409.3 - INR 838.8 |
| Market cap | INR 11387.7 Cr |
| From 52-week high | -11.30% |
| Volume vs average | 0.1x |
| Falling Shares risk score | 3/100 (LOW) |
| Country | India |
| ISIN | INE09XN01023 |
Frequently asked questions
Why is Akums Drugs and Pharmaceuticals Limited falling today?
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS.NS) is down 0.11% at its latest quote and trades 11.3% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Akums Drugs and Pharmaceuticals Limited share price today?
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS.NS) last traded at INR 743.8, a -0.11% move on the day as of 2026-11-08 10:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Akums Drugs and Pharmaceuticals Limited?
Akums Drugs and Pharmaceuticals Limited's 52-week low is INR 409.3 and its 52-week high is INR 838.8; the shares trade 11.3% below the high.
What is the market cap of Akums Drugs and Pharmaceuticals Limited?
Akums Drugs and Pharmaceuticals Limited has a market capitalisation of about INR 11387.7 Cr at the latest price.
What are the risks of investing in Akums Drugs and Pharmaceuticals Limited?
Falling Shares Intelligence rates Akums Drugs and Pharmaceuticals Limited 3/100 (LOW) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com